Endovascular management of chronic mesenteric ischemia.
Chronic mesenteric ischemia is a rare condition caused by occlusive disease of the mesenteric vessels. While the traditional therapy in symptomatic patients has been surgery, recent advances in interventional devices and techniques have made endovascular treatment feasible and effective. Mesenteric angioplasty and stenting has a technical success rate of 80 to 100% with a clinical efficacy of 80 to 95%. Published studies indicate a primary patency of 75 to 85%. This article presents a review of the literature and the technical aspects of the procedure.
Razavi
Mahmood
M
Vascular Center, H3651, University Hospital, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA. mrazavi@stanford.edu
Chung
Hwan-Hoon
HH
D017130:Angioplasty / Q000379:methods*; D002908:Chronic Disease; D006801:Humans; D007511:Ischemia / Q000601:surgery*; D017538:Mesenteric Artery, Superior / Q000601:surgery*; D008641:Mesenteric Vascular Occlusion / Q000601:surgery*; D015607:Stents